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   AMENVATTING
Inflammatory reactions in dogs are associated with systemic changes in serum, called the acute 
phase response; changes in the  concentration of acute phase proteins in the serum take place. 
C-reactive protein (CRP) is a positive acute phase protein, which increases during inflammation. 
The role of inflammation in epilepsy remains unclear. In this study, the inflammatory response 
in dogs with idiopathic epilepsy (IE) was investigated. The aims of the study were: 1. to measure 
serum CRP concentrations in dogs with IE and in healthy dogs, 2. to measure serum CRP 
concentrations in dogs with acute cluster seizures and in dogs with isolated seizures and 3. to 
observe the evolution of serum CRP concentrations in time after the last seizure. This study 
showed no significant differences in serum CRP concentrations between dogs with IE (7.8 mg/l) 
and dogs of the control group (8.3 mg/l). Furthermore, the results showed higher mean serum 
CRP concentrations in dogs with IE exhibiting cluster seizures (11,8 mg/l) than in dogs with 
isolated seizures (5.7 mg/l). However, these results were not statistically significant (P = 0,077). 
Finally, no statistically significant decrease in serum CRP concentrations was seen with time 
after the last epileptic seizure in dogs with IE  (P = 0,077).
ABSTRACT
Inflammatoire reacties bij honden zijn geassocieerd met systemische veranderingen in het serum, 
de acute fase respons genaamd. Deze gaat gepaard met veranderde concentraties acutefase-eiwitten 
in het serum. Het C-reactief proteïne (CRP) is een positief acutefase-eiwit en stijgt bijgevolg bij een 
ontsteking. Er bestaat veel onduidelijkheid over de relatie tussen epilepsie en ontsteking. Daarom 
werd in deze studie de rol van ontsteking onderzocht bij honden met idiopathische epilepsie (IE). Drie 
doelstellingen werden vooropgesteld: 1. het meten van serum-CRP-concentraties bij honden met IE en 
bij gezonde honden, 2. het meten van serum-CRP-concentraties bij honden met acute clusteraanvallen 
en bij honden met geïsoleerde aanvallen en 3. het opvolgen van de evolutie in serum-CRP-concentraties 
in de tijd na de laatste epilepsieaanval. In deze studie kon geen significant verschil in serum-CRP-
concentratie tussen honden met IE en de honden van de controlegroep worden aangetoond. Verder 
waren de gemiddelde serum-CRP-concentraties hoger bij honden met clusteraanvallen (8,3 mg/l) dan 
bij honden met geïsoleerde aanvallen (7,8 mg/l). Deze resultaten waren echter statistisch niet significant 
(P = 0,077). Ten slotte werd een statistisch niet-significante daling in serum-CRP-concentraties gezien 
na de laatste epileptische aanval bij de honden met IE (P = 0,077).
S
INTRODUCTION
Inflammatory reactions are associated with sys-
temic changes, also called the “acute phase response”, 
which leads to an increase of inflammatory cells in the 
blood, consequently resulting in raised serum cyto- 
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kines. These cytokines stimulate the synthesis of 
serum CRP, a positive acute phase protein, in hepa-
tocytes (Kushner, 1993; Gabay and Kushner, 1999; 
Volanakis, 2001; Mantovani et al., 2008; Lech et al., 
2013). Research has been performed on serum CRP 
changes in several human inflammatory diseases, but 
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little is known about the role of serum CRP in epilep-
sy (Alapirtti et al., 2012). Furthermore, there are still a 
lot of questions on the effect and role of inflammation 
in epilepsy. It is currently known that epileptic activ-
ity leads to inflammatory reactions in cerebrospinal 
fluid (CSF) and serum, both in humans and rodents. 
(Peltola et al., 1998; Vezzani et al., 2013). This results 
in an increase of interleukin-6 (IL-6) in both CSF and 
serum, and consequently, in a higher serum CRP con-
centration in humans (Lehtimäki et al., 2004). Epilep-
tic seizures can also provoke systemical inflamma-
tory reactions, which might cause structural cortical 
changes that can be responsible for propagation of 
the seizure. These changes, in particular an increased 
permeability for inflammatory cells through the brain-
blood barrier, appear due to chronic stimulation of cyto- 
kines (Penkowa et al., 2001; Janigro, 2012). 
Three hypotheses were investigated in this study. 
A higher serum CRP concentration was expected in 
dogs with IE than in healthy dogs of a control group, 
since in both the human and veterinary literature, it 
has been confirmed that epileptic activity leads to sys-
temical inflammatory reactions (Peltola et al., 1998; 
Vezzani et al., 2013). In human medicine, serum CRP 
alterations were investigated in patients with epilepsy 
(Peltola et al., 2002; Alapirtti et al., 2012; Sutter et 
al., 2013; Ishikawa et al., 2015), whereas veterinary 
studies are much more limited (Nakamura et al., 
2008; Holtman et al, 2013). Secondly, a higher serum 
CRP concentration was expected in dogs with cluster 
seizures (two or more seizures within 24 hours), than 
in dogs with isolated seizures (Lorenz et al., 2011). 
Probably, there is a more severe form of inflammation 
in cluster seizures, because of the high frequency of 
seizures during a short time-span. In only one study, 
serum CRP concentrations in humans with status epi-
lepticus (SE), which is also an acute and severe sei-
zure type, has been investigated. The results of this 
study showed no consistent association between se-
rum CRP concentration and the outcome of status epi-
lepticus (Sutter et al., 2013). So far, no other human 
or veterinary studies have already compared serum 
CRP concentrations in patients with cluster seizures/
SE and patients with isolated seizures. Finally, a high-
er serum CRP concentration was expected when the 
sample was taken closest to the last seizure, because 
a decrease in systemical inflammation could have oc-
cured in the period after seizure. This presumption has 
already been demonstrated in humans and rats, but 
not in dogs (Peltola et al., 2002; Alapirtti et al., 2012; 
Holtman et al., 2013).
MATERIALS AND METHODS
Patient selection
Serum samples were collected at the Small Animal 
Department of the Faculty of Veterinary Medicine, 
Ghent University (2015-2016). Serum CRP mea-
surement was only performed in dogs with IE whose 
blood had to be taken for other purposes such as gen-
eralized blood work or serum concentration monitor-
ing for standard follow-up of antiepileptic treatment. 
Inclusion criteria for dogs with IE were: 1. onset of 
seizures between six months and six years of age, 2. 
normal physical and neurological examination inter-
ictally (except for the neurological abnormalities due 
to the treatment with anti-epileptic drugs or due to 
seizure induced cerebral hypoxic/excitoxic damage), 
3. normal hematology, 4. normal biochemistry (Na, 
K, Cl, Ca, P, ALT, AST, AF, Gamma-GT, bile-acids 
(preprandial), NH3, bilirubin, urea, creatinine, total 
protein, albumin, glucose, cholesterol, triglycerides, 
total T4 (if total T4 was low, TSH was measured, and 
if still doubtfull, a TSH stimulation test was added) 
5. no abnormal findings on magnetic resonance im-
aging of the brain and cerebrospinal fluid analysis 
(cell count and protein measurement), if available. 
The timing between blood sampling, the last seizure 
and the fact whether the dog had isolated or cluster 
seizures, was tracked. The dogs in the control group 
were all healthy Beagles (aged between five and seven 
years) having no neurological abnormalities. These 
serum samples had been collected for another study at 
the Small Animal Department, Faculty of Veterinary 
Medicine, Ghent University. 
To complete the first and second part of the study, 
the sample closest to the seizure was used when more 
than one serum sample was available of the same dog. 
The evolution of serum CRP concentration in time af-
ter the last seizure was evaluated as a last part of this 
study. Serial samples, if available, were all included. 
The time after the seizure was described in four cate-
gories: 0-3 days, 4-14 days, 15 to 31 days, and more 
than 1 month after the last seizure.
Sample processing
Each sample was collected in a serum tube and 
centrifuged afterwards. A part of the serum was trans-
ferred into 2 ml tubes and preserved in a -80°C freezer 
awaiting further analysis. The CRP measurements 
were carried out at Idexx laboratories® using immuno- 
turbidimetry. Normal values ranged between 0 and 
10.7 mg/L.
Statistical analysis
The analytical program SPSS® was used to pro-
cess the data. For the first and second part of the study, 
an unpaired student T-test was conducted. One mg/L 
was added to each CRP concentration and was fol-
lowed by logarithmic transformation to obtain a value 
for each CRP concentration and to acquire a normal 
distribution. The mean CRP concentration (for the 
first part both in the IE and the control group, for the 
second part both in the group of dogs with cluster sei-
zures and in the group of dogs with isolated seizures) 
and 95%-confidence intervals were calculated. After-
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wards, every mean concentration was again converted 
to the actual CRP concentration and decreased by 1 
mg/L. For the third part of this study, a linear mixed 
regression model was built in order to take into ac-
count clustering of repeated observations. In every 
test, P < 0.05 was considered significant.
RESULTS
An overview of the number of dogs that was in-
cluded in each part of this study is displayed in Table 
1. In the first part of this study, in which serum CRP 
concentrations in dogs with and without IE were com-
pared, a total amount of 66 samples were collected in-
cluding 38 samples of dogs with IE and 28 samples of 
the dogs in the control group. In the second part of the 
study, 16 samples of dogs with cluster seizures and 22 
samples of dogs with isolated seizures were included 
so that a total amount of 38 samples were used in this 
part of the study. For the group of dogs with cluster 
seizures, the time between the seizure and the blood 
sample ranged from samples taken during the seizure 
to 53 days after the last seizure (mean: 9 days). For 
the group of dogs with isolated seizures, time ranged 
from 15 minutes to 304 days (mean: 49 days). For 
the last part of the study, in total, 50 samples of 37 
dogs were included. There were 27, 7 and 3 dogs that 
produced respectively 1, 2 and 3 samples. Each group 
contained respectively 13, 13, 12 and 12 dogs.
ln each part of this study, there was a normal dis-
tribution of the data after logarithmic transformation. 
An overview of mean serum CRP concentrations is 
displayed in Table 1. The mean serum CRP concen-
tration in dogs with IE [7.8 mg/ml ± standard error 
of the mean (SE) 0.09] was not different from the 
mean CRP concentration in the dogs of the control 
group (8.3 mg/ml ± 0.08) (P = 0.8). The results of the 
second part of this study showed higher mean serum 
CRP concentrations in the dogs with cluster seizures 
(11.8 mg/ml ± 0.08) than in the dogs with isolated 
seizures (5.7 mg/ml ± 0.13); however this was not 
statistically significant (P = 0.077). Finally, the serum 
CRP concentrations of four groups were compared, 
with the first group representing the shortest time and 
the fourth group the longest time after the last seizure. 
For the linear mixed regression model that was built, 
an overall P-value of 0.2 was obtained, which means 
that the time after the last seizure had no significant 
influence on the logarithmic serum CRP concentra-
tions in this study. However, when comparing mean 
serum CRP concentrations of group 1 (i.e. blood sam-
ple taken 0 to 3 days after last seizure) and group 4 
(i.e. blood sample taken more than one month after 
last seizure), a higher mean serum CRP concentration 
was present in group 1 (10.2 mg/l) than in group 4 
(3.4 mg/l). However, this result was not statistically 
significant (P = 0.077) (Figure 1).
DISCUSSION
The hypothesis that dogs with IE have increased 
serum CRP concentrations could not be confirmed in 
this study. This is in contradiction with certain human 
Figure 1. Mean logarithmical serum CRP concentrations 
of each group (group 1: 0-3 days after a seizure; group 
2: 4-14 days after a seizure; group 3: 15-31 days after a 
seizure; group 4: >1 month after a seizure). The error 
bars are representing the range of the 95%-confidence 
interval.
Table 1. Number of dogs and mean serum CRP concentration (in mg/l).
 Groups Number of dogs Mean CRP concentration
   (in mg/l)
IE vs. control Total 66 
 IE group 38 7.8
 Control group 28 8.3
Isolated vs. cluster seizures Total 38 
 Isolated seizures 22 5.7
 Cluster seizures 16 11.8
Time after seizure Total 50 
 0 - 3 Days after seizure 13 10.2
 4 - 14 Days after seizure 13 9.2
 15 - 31 Days after seizure 12 5.4
 > 1 Month after seizure 12 3.4
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studies where significantly higher serum CRP concen-
trations were found in patients with epilepsy (Alapirtti 
et al., 2012; Ishikawa et al., 2015). Moreover, these 
studies showed higher serum CRP concentrations in 
humans with generalized seizures than in humans 
with focal seizures. In the present study, these differ-
ent types of seizures were not compared. However, 
higher serum CRP concentrations were expected, due 
to the high frequency of generalized seizures in dogs 
with IE (Schwartz-Porsche, 1994; Knowles, 1998). 
On the contrary, in some human studies, no significant 
differences in serum CRP concentrations in patients 
with or without epilepsy could be found (Peltola et al., 
2002; Sutter et al., 2013). In one veterinary study, se-
rum CRP concentrations between dogs with epilepsy 
and healthy dogs were compared, but no differences in 
serum CRP concentrations were detected (Nakamura 
et al., 2008). In that study, dogs with all types of epi-
lepsy were included (Nakamura et al., 2008), whereas 
only dogs with IE were included in the present study, 
leading to a more homogenous population. It is pos-
sible that a significant difference in serum CRP con-
centrations in dogs with and without IE could not be 
found because the blood samples were not taken at 
the same time after seizure. The results suggest poten-
tially lower serum CRP concentrations when samples 
were taken later after the last seizure. Since the major-
ity of the samples were not taken soon after the last 
seizure, this might have influenced the results. The 
chance to detect a higher CRP concentration in dogs 
with IE than in the dogs of the control group, might 
have been higher when the serum sample would have 
been taken shortly after the last seizure. Another rea-
son might be that the dogs of the control group might 
have had a higher serum CRP concentration due to 
presence of a subclinical inflammation, but as all dogs 
of the control group appeared clinically healthy, this 
hypothesis is less likely.
The results of the second part of this study sug-
gest a potential difference in logarithmic transformed 
serum CRP concentrations between dogs with clus-
ter seizures and dogs with isolated seizures, although 
the results are not significant. It may be assumed that 
dogs with cluster seizures show a more severe form of 
inflammation than dogs with isolated seizures, as sei-
zures are more frequent over a short-term period and 
there is less time for the body to reduce the inflamma-
tion. So far, nothing has been described about serum 
CRP concentration in dogs with cluster seizures and 
dogs with isolated seizures. In a study by Sutter et al. 
(2013), a clear association between CRP levels and 
outcome in human patients with SE, another acute and 
severe seizure type, could not be demonstrated. Two 
other studies demonstrated higher serum CRP con-
centrations in humans with generalized versus focal 
seizures (Alapirtti et al., 2012; Ishikawa et al., 2015), 
but this was not investigated in the present study. 
Finally, the numerical differences in logarithmic 
serum CRP concentrations between group 1 (10.2 
mg/l) and group 4 (3.4 mg/l), indicate that lower se-
rum CRP concentrations might be expected when the 
sample is taken longer after the last seizure. However, 
this result was statistically not significant. In the lit-
erature, an increase in serum CRP concentrations has 
been described in the first hours after an epileptic sei-
zure both in humans and rats (Peltola et al., 2002; Ala-
pirtti et al., 2012; Holtman et al., 2013). In the present 
study, not all CRP concentrations were measured this 
soon after a seizure. The cause of a decrease in serum 
CRP concentrations during the days after the seizure 
could be due to a reduction of the inflammatory re-
sponse (Otabe et al., 2000). However, when CRP con-
centrations between all the groups were compared, 
no significant differences could be found, which 
may have multiple causes. 1. There is no difference 
in serum CRP concentration between dogs with and 
without IE. 2. The confidence intervals cover a wide 
range. When using a larger sample size, they may be-
come more dense (Figure 1). 3. The amount of serial 
samples was not the same for all of the dogs. 4. It 
might take more time for the CRP concentrations to 
decrease, but previously published work shows that 
the CRP molecule has a fast elimination halftime, 
which makes this hypothesis less likely (Young et al., 
1991; Shrive et al., 1996). 
As the sample size in this study was limited, future 
research using a larger patient group is necessary to 
support the results of this study.
CONCLUSION
In conclusion, inflammatory reactions might play 
a role in dogs with IE. In this study, no significant dif-
ferences in serum CRP concentrations in dogs with IE 
and dogs of the control group were shown. The results 
demonstrated lower mean CRP concentrations in dogs 
with cluster seizures than in dogs with isolated sei-
zures and lower mean CRP concentrations in samples 
taken longer after the last seizure. However, this could 
not be demonstrated with statistical significance. Not-
withstanding these findings, a larger sample size in 
each of the tested groups is required before final con-
clusions can be drawn. 
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